2013
DOI: 10.1093/cvr/cvt103
|View full text |Cite
|
Sign up to set email alerts
|

Efficient and specific cardiac IK1 inhibition by a new pentamidine analogue

Abstract: PA-6 has higher efficiency and specificity to KIR2.x-mediated current than P, lengthens action potential duration, and does not affect channel trafficking at concentrations relevant for complete IK₁ block.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
58
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(64 citation statements)
references
References 46 publications
6
58
0
Order By: Relevance
“…To illustrate, consider the partial inhibition of K + currents (for increasing APD 90 and thus ERP), in combination with drugs aimed at increasing CaT amp (for restoring contractility). Partial block of NKA with digoxin, combined with reduced RyR Ca 2+ leak using a calmodulin kinase II inhibitor, appeared to be beneficial in single cell simulations (Figure S11) and may actually become feasible in the near future, as novel specific blockers of I K1 are being developed [34]. The 1D restitution results (Figure S12) also illustrated increases in APD, ERP, CV and WL, which may be desirable in terms of protecting against arrhythmia.…”
Section: Discussionmentioning
confidence: 99%
“…To illustrate, consider the partial inhibition of K + currents (for increasing APD 90 and thus ERP), in combination with drugs aimed at increasing CaT amp (for restoring contractility). Partial block of NKA with digoxin, combined with reduced RyR Ca 2+ leak using a calmodulin kinase II inhibitor, appeared to be beneficial in single cell simulations (Figure S11) and may actually become feasible in the near future, as novel specific blockers of I K1 are being developed [34]. The 1D restitution results (Figure S12) also illustrated increases in APD, ERP, CV and WL, which may be desirable in terms of protecting against arrhythmia.…”
Section: Discussionmentioning
confidence: 99%
“…24 This study indicates that KCNJ2 is similarly predominant in fibroblasts: DN-KCNJ2 almost completely eliminated fibroblast I K1 ( Figure 5B, inset). I K1 blockers are being developed as potential antiarrhythmic molecules, 25,26 based on their ability to inhibit cardiomyocyte I K1 and destabilize AF-maintaining rotors. 26,27 An additional potentially interesting consequence, based on the work reported here, might be the suppression of atrial fibrosis.…”
Section: Novel Elements and Potential Significancementioning
confidence: 99%
“…In an effort to develop more specific Kir2.1 probes, the investigators analyzed a series of pentamidine analogs for activity toward Kir2.x and several other cardiac ion channels [27]. One compound termed PA-6 exhibited ~15 nM affinity toward Kir2.1, Kir2.2, and Kir2.3, but no discernible activity toward cardiac sodium, calcium, and potassium currents.…”
Section: Cardiac Kir2x Channelsmentioning
confidence: 99%
“…chloroquine [18], pentamidine [25,27], flecainide [33], fluoxetine [46,56], and nortriptyline [47]; Table 1) exhibiting Kir channel-directed activity creates opportunities for engineering more potent and selective Kir channel modulators from these chemical scaffolds (e.g. [27]). Chemically unique Kir channel inhibitors have been discovered in publically funded, large-scale screens of diverse chemical libraries, the results of which are deposited in well-annotated databases (http://pubchem.ncbi.nlm.nih.gov/).…”
Section: Cardiac Kir2x Channelsmentioning
confidence: 99%